Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 3INDUSTRY 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 53Neoplasms 8Urinary Bladder Neoplasms 4Neoplasm Metastasis 4Urinary Incontinence 3Erectile Dysfunction 3Pulmonary Disease, Chronic Obstructive 2Non-Muscle Invasive Bladder Neoplasms 2Lung Neoplasms 2Kidney Failure, Chronic 2Heart Failure 2Dementia 2Breast Neoplasms 2Weight Loss 1Urogenital Neoplasms 1Ureteral Neoplasms 1Turcot syndrome 1Recurrence 1Prostatic Neoplasms, Castration-Resistant 1Prostatic Diseases 1Prostate cancer, familial 1Prostate Cancer Prevention 1Prostate Cancer Diagnosis 1Patients With Prostate Cancer 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Obesity 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neoplasms by Site 1Motor Activity 1Male Urogenital Diseases 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Lung Diseases, Interstitial × Genitourinary × Clear all
NCT05001009 2024-12-27

LSTDI

VA Office of Research and Development

Phase NA Enrolling by invitation
72 enrolled
Genitourinary

Dementia, Heart Failure, Kidney Failure, Chronic, Neoplasms, Lung Diseases, Interstitial, Pulmonary Disease, Chronic Obstructive, End Stage Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡